Aktiesnakken — August 2010
-
-
nå nye?
-
-
det kan godt være vi skriver lidt for meget om genmab
-
det må vi håbe
-
sker d. 17
-
yepper
-
ja det er klogt at være meget forsigtig med genmab
-
vi har vist ikke kodet nogen stavekontrol
-
måske skal jeg lige tjekke om vi har et patent pending
-
og stort velkommen til iøvrigt!
- Ej de skal nok rejse sig igen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind